LC
AZN icon

Lavaca Capital’s AstraZeneca AZN Stock Holding History

Lavaca Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.7K Sell
100
-1,771
-95% -$341K ﹤0.01% 219
2025
Q4 		$344K Hold
1,871
– – 0.06% 76
2025
Q3 		$287K Hold
1,871
– – 0.05% 86
2025
Q2 		$261K Buy
+1,871
New +$262K 0.1% 93

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Lavaca Capital's AZN Position: Q1 2026 in Review

Lavaca Capital reduced its AstraZeneca (AZN) stake by 95% in Q1 2026, selling an estimated $341K and leaving 100 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #219.

Lavaca Capital first reported a position in AZN in Q2 2025 and has held it in 4 quarters since. The position peaked at $344K in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Lavaca Capital held 100 shares of AstraZeneca worth $19.7K as of Q1 2026.
  • Lavaca Capital sold 1,771 AstraZeneca shares in Q1 2026, an estimated $341K.
  • AstraZeneca made up ﹤0.01% of Lavaca Capital's portfolio in Q1 2026, its #219 holding.
  • Lavaca Capital first reported a position in AstraZeneca in Q2 2025 and has held it in 4 quarters since.
  • Lavaca Capital's AstraZeneca position peaked at $344K in Q4 2025.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.